Jan 10 2010, 12:10 AM, updated 3y ago
Hye guys, im introducing a killer product called Danshen plus capsule brought to you by TASLY GROUP from china. For those who are really care bout their health, please spend ur precious time to read some useful information about this product below. Trust me, u will not regret.
Introduction
After clinical application for eleven years and tremendous amount of scientific experiments, Danshen Plus, a precious modern Traditional Chinese Medicine (TCM), is proved to be capable of remarkable effects on protecting normal functions of blood vessel endothelium
. It is also proved that long-term used of Danshen Plus can reduce the occurrence of coronary heart disease and other cardiovascular diseases thus Danshen Plus has perfect effects on heart protection. Research shows that Danshen Plus assuages pain immediately in 40.2% patients and stops angina pectoris in 3-8 minutes in 48% patients with sublingual intake, making the total effective rate more than 88%. 
Moreover, clinical application reveals that Danshen Plus starts its effect as soon as nitroglycerin, so Danshen Plus Capsule can also be used to relieve pain immediately. In the 10 years clinical application, Danshen Plus Capsule is proved to have effects on protecting coronary heart disease and angina pectoris, meanwhile, Danshen Plus Capsule has good effects on other disease such as metabolic syndrome, thus it has protective functions on heart diseases.
*********************************************************************************************************
Highlight
01
Kasly Danshen Plus Capsule, with the precious ingredients of Salvia Miltiorrhiza, Notoginseng etc. It has similar function of anti-platelet aggregation as Aspirin. Moreover, it has effects on cholesterol and triglyceride reduction, blood viscosity reduction, general microcirculation improvement, anti-oxidation, free radical clearance, cardiac muscle protection, etc. These functions coordinate at multiple levels, aim at multiple targets, and act in multiple systems. Most effects function at key points of coronary heart disease. We strongly suggest that Kasly Danshen Plus Capsule should be used to fight coronary heart disease. And we suggest mid-age population (male>35 years old and female>40 years old) take Kasly Danshen Plus Capsule as early as possible, because their hearts should be taken care more seriously.
02
Brain infarction is commonly known as ‘brain stroke’. It includes the formation of blood clot and embolism. Incidence of brain stroke increases obviously in recent years. It also occurs more and more frequently in young people recently. Kasly Danshen Plus Capsule has the function to improve blood circulation by removing stasis. Clinical application proves that Kasly Danshen Plus Capsule and conventional therapies has good effects on patients suffering from brain stroke.
03
Microcirculation is the blood circulation between the capillary arterioles and venules. It’s used for the nutrient exchange between body, blood and tissue and brings oxigen and nutrient to tissues and takes away the metabolic productions. It has been proven by many researches that Kasly Danshen Plus Capsule can improve the body microcirculation. Research in Medical School of Keio University, Japan, has shown that Kasly Danshen Plus Capsule has a multi-target effect on microcirculation disturbance.
04
Kasly Danshen Plus Capsule has definite function to reduce blood lipid, especially function to cholesterol. Some researches have been done to patients of carotid atherosclerosis. Controlled by normal dosage of Aspirin, treatment with therapeutic dosage (10 cap x 3 times per day) Kasly Danshen Plus Capsule results in:
05
- Change of carotid intima-media thickness (IMT): Carotid IMT thickness decreased in the group treated with Kasly Danshen Plus Capsule (P<0.05), and there was no noticeable change in control group.
- Change of blood rheology: Blood viscosity of both groups decreased, but no remarkable difference between the treatment group and control group was observed (P>0.05).
- Change of blood lipid level: Patients in both groups have a high level of blood lipid. After treatment of Kasly Danshen Plus Capsule, cholesterol and triglyceride level were significant difference (p<0.01) between respondents and control groups.
06
Diabetic retinopathy and renopathy caused by microcirculation and capillary of diabetes patients, the common complications in micro blood vessels regarding to diabetes. Kasly Danshen Plus Capsule change the blood rheology, anti-calcium ion and reduce the triglyceride and cholesterol level. Therefore, Kasly Danshen Plus Capsule is highly recommended to diabetes complication patient.
Research On Tasly Danshen Plus Capsule
(effect on microcirculation after consuming Tasly Danshen Plus Capsule
in 30 min duration)
When someone is suffering from high blood pressure, he has seven times more likely to suffer stroke, four times to get a heart attack and five times more likely died because of heart failure.
Dr.Neil Md.-Solomon, PhD (John Hopkinsn Hospital & University)
**********************************************************************************************************
Latest News (Updated 24/6/2011)
DANSHEN PLUS PASSED THE SECOND FDA TEST
QUOTE
1st patent TCM passes US FDA clinical trials 2010-08-09 08:19:34 Source:China Daily
BEIJING - A China-made pill to treat cardiovascular conditions has been tested safe and effective by the US Food and Drug Administration (FDA), and, hopefully, will be marketed in the US as early as 2013, a pharmaceutical company said in Beijing Saturday.
Tianjin-based Tasly Pharmaceutical's Compound Danshen Dripping Pill, had passed the US FDA's Phase II clinical trials in July, one step closer to getting into the US and European drug market, the company's president Yan Xijun told a press conference in Beijing.
Clinical trials of the drug, composed of herbal extracts, was conducted in 15 test centers in the US over the last three years and had "generated positive results," Yan said.
With domestic sales of more than one billion yuan ($148 million) last year, the drug was the first Chinese patent traditional medicine to pass Phase II trials of the FDA, known for its strictness in approving drugs.
The FDA has also approved the drug to enter the Phase III trials, Yan said.
FDA Phase II trials gauge the effectiveness of a drug and its side effects and risks, while Phase III trials are more extensive.
Once Phase III is complete, a pharmaceutical company can request FDA approval for marketing the drug in the US.
Yan said the Shanghai-listed Tasly would build 50 to 70 clinical trial centers worldwide in the next 12 to 18 months for the Phase III trials, adding that he expected the pills to enter US and global drug markets within three years.
Compound Danshen Dripping Pill is mainly used to treat angina and coronary heart diseases. Already more than 10 million people worldwide take the pills annually, according to Tasly Pharmaceutical.
Previously, the drug had been approved by drug watchdogs in Canada, Russia, Republic of Korea, Vietnam, Singapore and some African countries.
BEIJING - A China-made pill to treat cardiovascular conditions has been tested safe and effective by the US Food and Drug Administration (FDA), and, hopefully, will be marketed in the US as early as 2013, a pharmaceutical company said in Beijing Saturday.
Tianjin-based Tasly Pharmaceutical's Compound Danshen Dripping Pill, had passed the US FDA's Phase II clinical trials in July, one step closer to getting into the US and European drug market, the company's president Yan Xijun told a press conference in Beijing.
Clinical trials of the drug, composed of herbal extracts, was conducted in 15 test centers in the US over the last three years and had "generated positive results," Yan said.
With domestic sales of more than one billion yuan ($148 million) last year, the drug was the first Chinese patent traditional medicine to pass Phase II trials of the FDA, known for its strictness in approving drugs.
The FDA has also approved the drug to enter the Phase III trials, Yan said.
FDA Phase II trials gauge the effectiveness of a drug and its side effects and risks, while Phase III trials are more extensive.
Once Phase III is complete, a pharmaceutical company can request FDA approval for marketing the drug in the US.
Yan said the Shanghai-listed Tasly would build 50 to 70 clinical trial centers worldwide in the next 12 to 18 months for the Phase III trials, adding that he expected the pills to enter US and global drug markets within three years.
Compound Danshen Dripping Pill is mainly used to treat angina and coronary heart diseases. Already more than 10 million people worldwide take the pills annually, according to Tasly Pharmaceutical.
Previously, the drug had been approved by drug watchdogs in Canada, Russia, Republic of Korea, Vietnam, Singapore and some African countries.
Can read this news (malay vir) also in UTUSAN MALAYSIA 23 JUN 2011...
**********************************************************************************************************
Item
Price : RM190 per bottle
**********************************************************************************************************
Dealing method: COD / Post (buyer bear)
Location of seller: Manjung, Seri Iskandar, juru, bukit mertajam, kepala batas.....
Contact method/details: PM or reply here or call 0195901154
Item(s) conditions: New
Reason for sale: Just business
***********************************************************************************************************
Latest Offer
RM 170 PER BOTTLE INCLUSIVE POSTAGE FEE!!!
***********************************************************************************************************
Related Certificate
1. Registered Product
http://i224.photobucket.com/albums/dd261/p...7/untitled2.jpg
2. Halal
http://i224.photobucket.com/albums/dd261/p...7/untitled1.jpg
3. An IND Certificate from FDA
http://i224.photobucket.com/albums/dd261/p.../untitled-1.jpg
************************************************************************************************************
successful buyer from lyn
1) SCCH 5 x danshen plus
This post has been edited by Panzero: Apr 11 2015, 03:06 PM
Quote
0.0154sec
0.45
5 queries
GZIP Disabled